Evidity Health Capital, formerly known as Canepa Healthcare, is a venture capital firm headquartered in New York, New York. It was founded in 2014. The company invests late stage and growth capital to medical device companies. It has invested heavily in the in vitro diagnostic and digital health sectors. The company's investment strategy has focused on investing in companies with commercialized products in need capital to reach sustainability.
In December 2019, the company announced that it would be changing its name from Canepa Healthcare to Evidity Health Capital.
A biotechnology company developing molecular-based diagnostic, prognostic, and predictive medical tests designed to help healthcare practitioners treat cancer.
EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Standard Molecular, Inc. is a Cambridge, Massachusetts-based company founded in 2014 by Chesley Leslin.
Sonde Health is a Boston-based digital health company developing voice-based technologies for monitoring and diagnosing mental and physical health.